Does use of isotretinoin rule out a career in flying?

British Journal of Ophthalmology

Volumn 90, Issue 8, 2006, Pages 957-959

  Mollan, Susan P ^a   Woodcock, M ^a,b   Siddiqi, R ^a   Huntbach, J ^b,c   Good, P ^a   Scott, R A H ^a,b  

^a CITY HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOID;

ACNE VULGARIS; ADULT; ARMY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; ELECTRORETINOGRAM; FEMALE; HUMAN; LABORATORY TEST; MALE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AEROSPACE MEDICINE; CAREER CHOICE; DARK ADAPTATION; ELECTRORETINOGRAPHY; FEMALE; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; NIGHT BLINDNESS; OCCUPATIONAL HEALTH; PERSONNEL SELECTION; RETINAL DISEASES; RETROSPECTIVE STUDIES; VISION DISORDERS;

EID: 33746510909     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.092833     Document Type: Article

References (13)

1. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004;292:726-35.
2. Oner A, Ferahbas A, Karakucuk S, et al. Ocular side-effects associated with systemic isotretinoin. J Toxicol 2004;23:189-95.
3. Fraunfelder FW. Ocular side-effects associated with isotretinoin. Drugs of Today 2004;40:23-7.
4. Brown RD, Grattan CEH. Visual toxicity of synthetic retinoids. Br J Ophthalmol 1989;73:286-8.
5. Weleber RG, Denman ST, Hanifin JM, et al. Abnormal retinal function associated with Isotretinoin therapy for acne. Arch Ophthalmol 1986;104:831-7.
6. Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with Isotretinoin usage. Am J Ophthalmol 2001;132:299-305.
7. Fraunfelder FT, Fraunfelder FW, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology 2004;111:1248-50.
8. Kaiser-Kupfer MI, Peck GL, Caruso RC, et al. Abnormal retinal function associated with fenretinidine, a synthetic retinoid. Arch Ophthalmol 1986;104:69-70.
9. Sieving PA, Chaudhry P, Kondo M, et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci USA 2001;98:1835-40.
10. Marmor MF, Holder GE, Seeliger MW, et al. Standard for clinical electroretinography (2004 update). Doc Ophthalmol 2004;108:107-14.
11. Calibration Standard Committee of the International Society for Clinical Electrophysiology of Vision (ISCEV). Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Doc Ophthalmol 2003;107:185-93.
12. British National Formulary 50, Oral preparations for acne.13.6.2. London: BMJ Publishing Group Ltd and Royal Pharmaceutical Society of Great Britain, Sept, 2005.
13. Halliday PM. Evoked potentials in clinical testing. Edinburgh: Churchill Livingstone, 1993:128-9.